By Hannah Albarazi ( January 15, 2020, 10:45 PM EST) -- A California federal judge overseeing Illumina's patent infringement suit against China-based BGI Genomics over DNA sequencing technology gave a mixed response to BGI's counterclaims at a hearing Wednesday, saying BGI's induced infringement claim had factual support while its inequitable conduct claim didn't....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.